HHMI
LRCX icon

Howard Hughes Medical Institute’s Lam Research LRCX Stock Holding History

Howard Hughes Medical Institute’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54M Hold
17,396
– – 1.69% 15
2026
Q1 		$3.72M Buy
17,396
+17,126
+6,343% +$3.83M 0.89% 18
2025
Q4 		$46.2K Sell
270
-2
-0.7% -$311 0.03% 45
2025
Q3 		$36.4K Sell
272
-5
-2% -$529 0.02% 58
2025
Q2 		$27K Buy
+277
New +$22K 0.01% 85
2015
Q4 		– Sell
-86,910
Closed -$568K – 181
2015
Q3 		$568K Buy
86,910
+7,790
+10% +$57.1K 0.11% 89
2015
Q2 		$644K Sell
79,120
-44,660
-36% -$351K 0.14% 89
2015
Q1 		$869K Buy
123,780
+22,370
+22% +$177K 0.12% 75
2014
Q4 		$805K Buy
101,410
+36,250
+56% +$281K 0.22% 67
2014
Q3 		$487K Buy
65,160
+49,190
+308% +$351K 0.11% 79
2014
Q2 		$108K Buy
+15,970
New +$95.4K 0.02% 119

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Howard Hughes Medical Institute's LRCX Position: Q2 2026 in Review

Howard Hughes Medical Institute held its Lam Research (LRCX) position steady in Q2 2026 at 17,396 shares worth $7.54M. The position accounts for 1.69% of the portfolio, ranked #15.

Howard Hughes Medical Institute first reported a position in LRCX in Q2 2014 and has held it in 11 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Howard Hughes Medical Institute held 17,396 shares of Lam Research worth $7.54M as of Q2 2026.
  • Howard Hughes Medical Institute left its Lam Research share count unchanged in Q2 2026.
  • Lam Research made up 1.69% of Howard Hughes Medical Institute's portfolio in Q2 2026, its #15 holding.
  • Howard Hughes Medical Institute first reported a position in Lam Research in Q2 2014 and has held it in 11 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2026, filed 14 Aug 2026.